The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; none of the 29 sources its claims cite is checked for support yet.
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
Open accessAbstract
Two Krebs cycle genes, fumarate hydratase ( FH ) and succinate dehydrogenase ( SDH ), are mutated in a subset of human cancers, leading to accumulation of their substrates, fumarate and succinate, respectively. Here we demonstrate that fumarate and succinate are competitive inhibitors of multiple α-ketoglutarate (α-KG)-dependent dioxygenases, including histone demethylases, prolyl hydroxylases, collagen prolyl-4-hydroxylases, and the TET (ten-eleven translocation) family of 5-methlycytosine (5mC) hydroxylases. Knockdown of FH and SDH results in elevated intracellular levels of fumarate and succinate, respectively, which act as competitors of α-KG to broadly inhibit the activity of α-KG-dependent dioxygenases. In addition, ectopic expression of tumor-derived FH and SDH mutants inhibits histone demethylation and hydroxylation of 5mC. Our study suggests that tumor-derived FH and SDH mutations accumulate fumarate and succinate, leading to enzymatic inhibition of multiple α-KG-dependent dioxygenases and consequent alterations of genome-wide histone and DNA methylation. These epigenetic alterations associated with mutations of FH and SDH likely contribute to tumorigenesis.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Fumarate and succinate, which accumulate when FH or SDH is lost, act as α-KG competitors and suppress multiple α-KG-dependent dioxygenases, including histone demethylases and TET DNA hydroxylases. This connects FH/SDH mutations to broad histone and DNA methylation changes that may contribute to tumorigenesis.
Key findings
- In vitro, fumarate and succinate inhibited CeKDM7A by more than 80% at 1–10 mM; for HsKDM4A, fumarate caused 22%, 41%, and 73% inhibition and succinate caused 43%, 68%, and 85% inhibition at 1, 3, and 10 mM, with succinate more potent (IC50 0.8 mM) than fumarate (IC50 1.5 mM).
- In cultured cells, cell-permeable fumarate or succinate increased H3K4 monomethylation about fourfold, H3K27 and H3K79 dimethylation about fourfold and threefold, and H3K4 trimethylation about twofold; FH or SDHA/B knockdown increased histone methylation three- to fivefold, raised HIF1α about fivefold, and lowered endostatin about sevenfold, effects diminished by cell-permeable α-KG.
- TET-catalyzed 5hmC production was reduced in FH, SDHA, or SDHB knockdown cells by 71%, 73%, and 82% for TET1 and by 80%, 83%, and 69% for TET2; in mouse liver, Fh or Sdha knockdown reduced 5hmC by 72% and 63% and increased Hoxa gene expression more than tenfold.
- Tumor-derived mutants were impaired: FH R190H and H137R retained 17% and 10% of wild-type activity; SDHA G555E and R554W retained 51% and 46%; SDHB R46Q and A43P retained 48% and 61%; wild-type but not mutant re-expression restored demethylation and 5hmC and reduced fumarate/succinate.
Methods
- In vitro demethylase assays used synthetic H3K9me1 and H3K36me3 peptides with MALDI-TOF/TOF mass spectrometry; FH and SDH enzyme activities were measured by absorbance-based assays.
- Cell work used HeLa and HEK293T cells with siRNA or stable knockdown of FH, SDHA, or SDHB, treatment with cell-permeable fumarate/succinate or octyl-α-KG, and TET1/TET2 catalytic-domain expression; readouts included GC-MS, Western blot, immunofluorescence, dot blot, and quantitative RT-PCR.
- In vivo work used hydrodynamic tail-vein siRNA delivery to knock down mouse liver Fh or Sdha (n = 3 per group); statistics used two-tailed unpaired Student’s t-test, triplicate experiments, and P < 0.05.
Limitations
- The paper notes an alternative product-inhibition model, observes that the succinate/α-KG ratio did not change in cells expressing tumor-derived FH mutants, and states that FH/SDH tumorigenesis may involve mechanisms independent of α-KG-dependent dioxygenases; it also says fumarate-mediated KEAP1 succination and NRF2 signaling require further exploration.
- The corrigendum reports that Figure 2B mislabeled SDHA and SDHB as FH and duplicated an actin control, though the authors state this does not affect the conclusions.
- Evident from the text: TET inhibition is inferred mainly from 5hmC readouts rather than direct TET enzyme kinetics, and the study relies on knockdown/overexpression and cell-permeable metabolite esters rather than direct human tumor metabolite-epigenome correlations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 29 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Here we demonstrate that fumarate and succinate are competitive inhibitors of multiple a-ketoglutarate (a-KG)dependent dioxygenases, including histone demethylases, prolyl hydroxylases, collagen prolyl-4-hydroxylases, and the TET (ten-eleven translocation) family of 5-methlycytosine (5mC) hydroxylases.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ectopic expression of tumor-derived FH and SDH mutants inhibits histone demethylation and hydroxylation of 5mC.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Fumarate and succinate inhibit the demethylase activity of human KDM4A (HsKDM4A) toward trimethylated H3K36, determined by mass spectrometry (MS) assay as in B.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cotransfection with wild-type FH, SDHA, or SDHB, but not their mutants (i.e., FH R190H , SDHA G555E , or SDHB R46Q ), could rescue the reduction of 5hmC levels in FH or SDH stable knockdown cells”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Knocking down FH or SDH reduces the TET-catalyzed 5hmC production in cultured cells.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cell-permeable fumarate (2.5 mM) or succinate (5 mM) increases histone methylation and HIF1a and reduces endostatin in HEK293T cells (left) and HeLa cells (right), as determined by Western-blot.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cell-permeable octyl-a-KG (5mM) diminishes the effect of FH or SDH suppression on increasing histone methylations, accumulating HIF1a, and decreasing endostatin in HEK293T cells with knockdown of FH (left panel), SDHA (middle panel), and SDHB (right panel), as determined by Western blot.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Succinate is more potent to inhibit HsKDM4A than fumarate.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 30
- The quote only partly states this claim. 6
- Probably not a substantial claim. 6
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Knockdown of FH and SDH results in elevated intracellular levels of fumarate and succinate, respectively”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Knockdown of FH, SDHA, and SDHB reduced TET1-induced 5hmC levels by 71%, 73%, and 82%, respectively, as compared with control cells coinfected with retrovirus containing the control shRNA vector pMKO.”
- Also stated in: § Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells · plain
“A virtually identical result was obtained for TET2-catalyzed 5hmC production, which was also decreased by 80%, 83% and 69% in cells with stable knockdown of FH, SDHA, and SDHB, respectively.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“At 12-h after siRNA injection, we were able to achieve 62% and 78% reduction of Fh and Sdha mRNA expression, respectively, in mouse livers”
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · plain
“hepatic expression of Fh and Sdha proteins was decreased by threefold and twofold, respectively”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the activity of FH R190H (the most frequent mutation in hereditary leiomyomatosis and renal cell cancer [HLRCC] patients) and FH H137R is only 17% and 10%, respectively, of wild-type FH”
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
“The activity of tumor-derived mutants SDHA G555E and SDHA R554W is 51% and 46%, respectively, of wild-type SDHA, and the activity of SDHB R46Q (the most frequent SDHB mutation in paraganglioma) and SDHB A43P mutants is 48% and 61%, respectively, of wild-type SDHB.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“addition of 2.5 mM methyl-fumarate and 5 mM methyl-succinate to the cultured HeLa cells resulted in a significant increase of intracellular fumarate and succinate, respectively, as determined by gas chromatography-mass spectrometry (GC-MS)”
- Also stated in: § Both fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells · plain
“The fumarate/ a-KG and succinate/a-KG ratios were elevated in these cells”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
- Also stated in: § Both fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Addition of 1 mM, 3 mM, and 10 mM fumarate resulted in >80% inhibition of CeKDM7A”
- Also stated in: § Both fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro · plain
“inhibition of CeKDM7A by fumarate or succinate became less effective, along with increased concentrations of a-KG”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
- Also stated in: § Both fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Transient knockdown of Fh or Sdha by siRNA significantly decreased 5hmC in liver cells, especially near hepatic portal veins”
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · boosted
“a dot blot assay demonstrated that 5hmC production was decreased by 72% and 63% in the livers of Fh and Sdha siRNA knockdown mice, respectively”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cell-permeable fumarate and succinate increased H3K4 monomethylation (by fourfold), H3K27 and H3K79 dimethylation (by fourfold and threefold, respectively), and H3K4 trimethylation (by twofold)”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“depletion of FH and SDHA/B by siRNA resulted in elevated levels of fumarate and succinate in HeLa cells, as determined by GC-MS assay”
- Also stated in: § Fumarate and succinate alter epigenetics · plain
“Knocking down FH and SDHA/B resulted in a significant increase of histone methylations on H3K4, H3K9, and H3K79 (by threefold to fivefold); accumulation of HIF1a (by fivefold); and a decrease of endostatin (by sevenfold)”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Fumarate and succinate alter epigenetics
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Fumarate and succinate alter epigenetics · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“knockdown of FH or SDHA/B resulted in up-regulation of several HOXA genes (e.g., HOXA2, HOXA4, and HOXA5)”
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
“Re-expression of wild-type FH or SDH reduced HOXA gene expression to the control levels.”
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
“In contrast, re-expression of mutant FH or SDH had no effect or even increased HOXA gene expression”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
In the paper
“Transient knockdown of Fh in mouse livers significantly increased monomethylation on H3K4 (by 2.5-fold); dimethylation on H3K9 (by 4.2fold), H3K27 (by 4.3-fold), and H3K79 (by 5.2-fold); and trimethylation on H3K4 (by 2.8-fold).”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
What the sources say
- Not checked yetcites Krivtsov et al. 2008
Tests✗ Asserted: fails✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The authors may not put it forward as true. The paper may give no reason why it holds. It may state two separate claims as one. The quote only partly states this claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Transient knockdown of Fh or Sdha in mouse livers led to accumulation of intracellular fumarate or succinate, respectively, as determined by GC-MS”
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · plain
“Notably, the succinate/a-KG ratio was also elevated in Fh knockdown liver cells, although less dramatically than Sdha knockdown.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tumor-derived FH or SDH mutants are not functional in fumarate or succinate metabolism.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The 5hmC level in most cultured cells is undetectable, but is substantially increased in cells transiently expressing the wild-type catalytic domain of TET1 and TET2 proteins (TET1-CD and TET2-CD)”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells
What the sources say
- Not checked yetcites Tahiliani et al. 2009
- Not checked yetcites Ito et al. 2010
- Not checked yetcites He et al. 2011
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ectopic expression of wild-type FH or SDHA/B resulted in decreases of dimethylation on H3K9 (by 1.5fold) as well as monomethylation and trimethylation on H3K4 (by 2.5-fold and twofold, respectively), consistent with increased KDM activity”
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
“these changes in genome-wide histone methylations were not observed in cells re-expressing tumor-derived FH or SDHA/B mutants”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases
Tests✗ Asserted: fails✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The authors may not put it forward as true. The paper may give no reason why it holds. It may state two separate claims as one. The quote only partly states this claim.
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that cell-permeable fumarate and succinate increased HIF1a and decreased endostatin in both cell types”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our results demonstrated that succinate (IC 50 = 0.8 mM) is more potent than fumarate (IC 50 = 1.5 mM) in inhibiting HsKDM4A”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Addition of 5 mM octyl-a-KG diminished the effect of FH or SDHA/B suppression on increasing histone methylations, accumulating HIF1a, and decreasing endostatin”
- Also stated in: § Fumarate and succinate alter epigenetics · plain
“these effects of octyl-a-KG were in a dose-dependent manner”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Fumarate and succinate alter epigenetics
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
- Also stated in: § Fumarate and succinate alter epigenetics · plain
None of the sources cited for this claim have been checked yet.
In the paper
“Thus far, all functionally characterized FH or SDH mutations result in either a complete loss or reduction of enzymatic activity (Tomlinson et al. 2002;Pollard et al. 2005), indicating that both FH and SDH function as tumor suppressors.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Tomlinson et al. 2002
- Not checked yetcites Pollard et al. 2005
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“These mutations in IDH1/2 result in simultaneous loss and gain of activities in the production of a-ketoglutarate (a-KG) and 2-hydroxyglutarate (2-HG), respectively”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Dang et al. 2009
- Not checked yetcites Yan et al. 2009
- Not checked yetcites Zhao et al. 2009
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Of the >60 estimated a-KGdependent dioxygenases in mammalian cells (Rose et al. 2011), the JmjC domain-containing histone demethylases (KDMs) and the TET (ten-eleven translocation) family of DNA hydroxylases play central roles in epigenetic control of genomic information.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Rose et al. 2011
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These enzymes require Fe(II) as a cofactor metal and a-KG as a cosubstrate to catalyze the reactions in which one oxygen atom from molecular oxygen (O 2 ) is attached to a hydroxyl group in the substrate (hydroxylation) while the other is taken up by a-KG, leading to the decarboxylation of a-KG and subsequent release of carbon dioxide (CO 2 ) and succinate.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our study suggests that tumor-derived FH and SDH mutations accumulate fumarate and succinate, leading to enzymatic inhibition of multiple a-KG-dependent dioxygenases and consequent alterations of genome-wide histone and DNA methylation.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“the recently discovered TET family of DNA hydroxylases catalyzes a three-step iterative oxidation reaction: converting 5mC to 5-hydroxymethylcytosine (5hmC), then converting 5hmC to 5-formylcytosine (5fC), and finally converting 5fC to 5-carboxylcytosine (5caC)”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Tahiliani et al. 2009
- Not checked yetcites Ito et al. 2010
- Not checked yetcites He et al. 2011
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“We and others recently demonstrated that ectopic expression of tumor-derived mutated IDH1 and IDH2 inhibits the activity of a-KG-dependent dioxygenases and, more importantly, produces 2-HG, which acts as an antagonist of a-KG to competitively inhibit the activity of a-KG-dependent dioxygenases, including both KDMs and TETs”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Chowdhury et al. 2011
- Not checked yetcites Xu et al. 2011
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies into the mechanism behind how mutations in FH and SDH trigger elevated levels of HIF1a provided evidence that fumarate and succinate accumulated in cells with mutations in either FH or SDH inhibit prolyl hydroxylases (PHDs), which hydroxylates and promotes the degradation of HIF1a”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Epstein et al. 2001
- Not checked yetcites Yu et al. 2001
- Not checked yetcites Isaacs et al. 2005
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Given the dependence of TET catalytic activity on a-KG and its inhibition by 2-HG (Xu et al. 2011)”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells
What the sources say
- Not checked yetcites Xu et al. 2011
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, alterations of histone methylation will likely have a broad impact on gene expression, which may also contribute to the tumor suppressor functions of FH and SDH.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Re-expression of wild-type FH and SDH dramatically reduced fumarate and succinate, respectively, in the FH or SDH knockdown cells and thus increased 5hmC by relieving inhibition on TETs.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Taken together, the above findings provide in vivo evidence supporting the notion that decreased activity of FH and SDHA leads to accumulation of fumarate and succinate, which inhibit a-KG-dependent dioxygenases and regulate target gene expression.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Taken together, these data indicate that knockdown of FH and SDHA/B leads to elevated levels of intracellular fumarate and succinate, respectively, which act as competitors of a-KG to inhibit TET-catalyzed hydroxylation of 5mC.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These observations suggest that tumor cells containing FH or SDH mutations accumulate fumarate and succinate, which then inhibit histone and DNA demethylations.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Suppression of Fh or Sdha did not significantly affect the hepatic mRNA levels of Tet genes”
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · hedged
“indicating that transient knockdown of Fh or Sdha would inhibit the activity of TETs by not down-regulating the transcription of TET genes.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · hedged
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these results suggest that both fumarate and succinate act as antagonists of a-KG to inhibit a-KG- dependent KDMs, with succinate being more potent than fumarate.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
TET family enzymes function as tumor suppressors.
“Given the well-characterized tumor suppressor function of TET”
The paper relies on this without support.
Many missense mutations in FH or SDH have unknown functional consequences.
“There are also many missense mutations whose exact functional consequences have not been characterized.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Like D-2HG, fumarate and succinate accumulation can inhibit some αKG-dependent dioxygenases, resulting in hypermethylation of DNA and histones in tumors exhibiting loss of FH or SDH (Hoekstra et al., 2015; Letouze et al., 2013; Xiao et al., 2012).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Xiao et al., 2012
In the citing paper
“Like 2HG accumulation, increased levels of succinate and fumarate can inhibit Jumonji C-domain–containing histone demethylases and TET enzymes, driving a widespread hypermethylation phenotype that disrupts normal cell differentiation (179, 180).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [180]
In the citing paper
“Tumors that exhibit SDH- and FH loss share a number of phenotypic features that are consistent with dioxygenase inhibition, among which is a characteristic global increase in DNA methylation (Killian et al., 2013; Letouze et al., 2013; Xiao et al., 2012), as well as elevated levels of HIF1α (Selak et al., 2005).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Xiao et al., 2012
In the citing paper
“Finally, it was shown that fumarate can drive succination of several members of the family of Iron Sulfur (Fe-S) cluster biogenesis proteins, causing a depletion of Fe-S clusters required for the activity of mitochondrial enzymes, including complex I88.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [88]
In the citing paper
“Succinate inhibits HIF-1␣ signaling through inhibition of PHD2 but can also impact the activity of numerous ␣-ketoglutarate-dependent dioxygenases (42,43).”
From Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels (2016) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
KDM7A substrate is described as both dimethylated and monomethylated
MinorThe assay description calls the H3K9 substrate dimethylated, but the peptide it says was used is monomethylated.
“To measure CeKDM7A demethylase activity toward dimethylated H3K9,”
“synthetic monomethylated peptide corresponding to monomethylated H3K9 (ARTKQTARK (me1)STGGKA) was used as substrate.”
Citations
Cites
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · cited 2×
“Thus far, all functionally characterized FH or SDH mutations result in either a complete loss or reduction of enzymatic activity (Tomlinson et al. 2002; Pollard et al. 2005), indicating that both FH and SDH function as tumor suppressors.”
BackgroundInfluentialIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“…species (ROS) that induce DNA damage and genomic instability (Kaelin 2009), and (3) provoke accumulation of HIF1a, a transcription factor whose stabilization and elevation could promote cell metabolism and angiogenesis (Ivan et al. 2001; Jaakola et al. 2001; Ling et al. 2005; Selak et al. 2005).”
BackgroundSelf-citationCancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · cited 3×
“…mutated IDH1 and IDH2 inhibits the activity of a-KG-dependent dioxygenases and, more importantly, produces 2-HG, which acts as an antagonist of a-KG to competitively inhibit the activity of a-KG-dependent dioxygenases, including both KDMs and TETs (Chowdhury et al. 2011; Xu et al. 2011).”
BackgroundSelf-citationTet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
He, Y., Li, B.-Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. (2011) · Science · doi:10.1126/science.1210944 · Cited by 2,776
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 999
Metabolic Plasticity and Epithelial-Mesenchymal Transition
Thomson, T. M., Balcells, C. D., & Cascante, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070967 · Cited by 39
Metabolite regulation of epigenetics in cancer
Wang, P., Chen, L., Xiong, Y., & Ye, D. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114815 · Cited by 50
Self-citationTargeting metabolic pathways for head and neck cancers therapeutics
Yamamoto, M., Inohara, H., & Nakagawa, T. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9691-z · Cited by 44
Epigenetic changes in fibroblasts drive cancer metabolism and differentiation
Mishra, R., Haldar, S., Suchanti, S., & Bhowmick, N. A. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0347 · Cited by 47
Muscle-Liver Substrate Fluxes in Exercising Humans and Potential Effects on Hepatic Metabolism
Hu, C., Hoene, M., Plomgaard, P., Hansen, J. S., Zhao, X., Li, J., Wang, X., Clemmesen, J. O., Secher, N. H., Häring, H. U., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz266 · Cited by 44
Epigenetic dynamics in cancer stem cell dormancy
Ferrer, A. I., Trinidad, J. R., Sandiford, O. A., Etchegaray, J., & Rameshwar, P. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09882-x · Cited by 44
Badur, M. G., & Metallo, C. M. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.11.013 · Cited by 44
Macrophage activation as an archetype of mitochondrial repurposing
Jones, A. E., & Divakaruni, A. S. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100838 · Cited by 41
Sturm, G., Monzel, A. S., Karan, K. R., Michelson, J., Ware, S. A., Cárdenas, A., Lin, J., Bris, C., Santhanam, B., Murphy, M. P., et al. (2022) · Scientific Data · doi:10.1038/s41597-022-01852-y · Cited by 41
Human Fumarate Hydratase Is Dual Localized by an Alternative Transcription Initiation Mechanism
Dik, E., Naamati, A., Asraf, H., Lehming, N., & Pines, O. (2016) · Traffic · doi:10.1111/tra.12397 · Cited by 44
Armstrong, N., Storey, C. M., Noll, S. E., Margulis, K., Soe, M. H., Xu, H., Yeh, B. T., Fishbein, L. M., Kebebew, E., Howitt, B. E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110453 · Cited by 42
Bailey, P. S. J., & Nathan, J. A. (2018) · Biomedicines · doi:10.3390/biomedicines6020060 · Cited by 41
Analyzing Tumor Metabolism In Vivo
Faubert, B., & DeBerardinis, R. J. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-121954 · Cited by 44
Sinton, M. C., Hay, D. C., & Drake, A. J. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0702-5 · Cited by 44
20 years of histone lysine demethylases: From discovery to the clinic and beyond
Gray, Z. H., Honer, M. A., Ghatalia, P., Shi, Y., & Whetstine, J. R. (2025) · Cell · doi:10.1016/j.cell.2025.02.023 · Cited by 59
Eeckhoute, J., Oger, F., Staels, B., & Lefèbvre, P. (2012) · PPAR Research · doi:10.1155/2012/164140 · Cited by 45
Zhou, Z., Ibekwe, E., & Chornenkyy, Y. (2018) · Antioxidants · doi:10.3390/antiox7010016 · Cited by 44
The crisscross between p53 and metabolism in cancer
Mao, Y., & Jiang, P. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023109 · Cited by 45
Molecular markers of paragangliomas/pheochromocytomas
Zhikrivetskaya, S. O., Snezhkina, A. V., Zaretsky, A. R., Alekseev, B. Y., Pokrovsky, A. V., Golovyuk, A. L., Melnikova, N. V., Stepanov, O. A., Kalinin, D. V., Moskalev, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15201 · Cited by 45
Role of oxygen and the HIF-pathway in polycystic kidney disease
Buchholz, B., & Eckardt, K. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109524 · Cited by 46
Succinate at the Crossroad of Metabolism and Angiogenesis: Roles of SDH, HIF1α and SUCNR1
Atallah, R., Olschewski, A., & Heinemann, Á. (2022) · Biomedicines · doi:10.3390/biomedicines10123089 · Cited by 43
Structure and Function of TET Enzymes
Yin, X., & Xu, Y. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43624-1_12 · Cited by 48
Self-citationDecoding the role of TET family dioxygenases in lineage specification
Wu, X., Li, G., & Xie, R. (2018) · Epigenetics & Chromatin · doi:10.1186/s13072-018-0228-7 · Cited by 43
Bénit, P., Goncalves, J., El‐Khoury, R., Rak, M., Favier, J., Gimenez‐Roqueplo, A., & Rustin, P. (2022) · Biomedicines · doi:10.3390/biomedicines10081788 · Cited by 49
The effects of microbiota on reproductive health: A review
Wang, N., Chen, L., Yi, K., Zhang, B., Li, C., & Zhou, X. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2117784 · Cited by 51
Metabolic Signaling to Epigenetic Alterations in Cancer
Kim, J., & Yeom, Y. I. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.185 · Cited by 45
The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
Song, P., Zhang, J., Tan, X., Huang, Y., Xu, J., Silk, N., Zhang, D., Liu, Q., & Jiang, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.586857 · Cited by 42
Oxidative stress and metabolism meet epigenetic modulation in physical exercise
García‐Giménez, J. L., Cánovas‐Cervera, I., & Pallardó, F. V. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.008 · Cited by 50
A New Specific Succinate-Glutamate Metabolomic Hallmark in Sdhx-Related Paragangliomas
Impériale, A., Moussallieh, F., Sebag, F. A., Brunaud, L., Barlier, A., Elbayed, K., Bachellier, P., Goichot, B., Pacák, K., Namer, I. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080539 · Cited by 43
The Role of Tumor Metabolic Reprogramming in Tumor Immunity
Zhang, X., Song, W., Gao, Y., Zhang, Y., Zhao, Y., Hao, S., & Ni, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417422 · Cited by 48
Role of succinic acid in the regulation of sepsis
Liu, H., Zhang, H., Zhang, X., Chen, Q., & Xia, L. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109065 · Cited by 43
Hyperglycemic memory in diabetic cardiomyopathy
Zhan, J., Chen, C., Wang, D. W., & Li, H. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0881-2 · Cited by 42
TET proteins in cancer: Current ‘state of the art’
Rawłuszko-Wieczorek, A. A., Siera, A., & Jagodziński, P. P. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.07.008 · Cited by 40
Fletcher, S. C., & Coleman, M. L. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190333 · Cited by 44
Richter, S., Qin, N., Pacak, K., & Eisenhofer, G. (2013) · Advances in Pharmacology · doi:10.1016/b978-0-12-411512-5.00014-2 · Cited by 42
Tarhonskaya, H., Nowak, R. P., Johansson, C., Szykowska, A., Tumber, A., Hancock, R. L., Lang, P. A., Flashman, E., Oppermann, U. C. T., Schofield, C. J., et al. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.08.007 · Cited by 45
The remodel of the “central dogma”: a metabolomics interaction perspective
dos Santos, G. C., Renovato‐Martins, M., & de Brito, N. M. (2021) · Metabolomics · doi:10.1007/s11306-021-01800-8 · Cited by 48
Cao, L., Liu, H., Yue, Z., et al. (2018) · BioMetals · doi:10.1007/s10534-018-0123-5 · Cited by 42
Karigane, D., & Takubo, K. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2261-x · Cited by 40
Zheng, Y., Chen, X., Zhang, D., Wang, W., Peng, K., Li, Z., Mao, Z., & Tan, C. (2023) · Chemical Science · doi:10.1039/d3sc01737k · Cited by 42
The Role of Succinic Acid Metabolism in Ovarian Cancer
Xia, L., Zhang, H., Wang, X., Zhang, X., & Nie, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.769196 · Cited by 34
Rubas, N. C., Torres, A., & Maunakea, A. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178658 · Cited by 46
Metabolic Adjustments following Glutaminase Inhibition by CB-839 in Glioblastoma Cell Lines
Santos-Jiménez, J. D. L., Rosales, T. I., Ko, B., Campos-Sandoval, J. A., Alonso, F. J., Márquez, J., DeBerardinis, R. J., & Matés, J. M. (2023) · Cancers · doi:10.3390/cancers15020531 · Cited by 40
Metabolic Drivers in Hereditary Cancer Syndromes
Sciacovelli, M., Schmidt, C., Maher, E. R., & Frezza, C. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033612 · Cited by 39
Targeted therapy in SDH- deficient GIST
Nannini, M., Rizzo, A., Indio, V., Schipani, A., Astolfi, A., & Pantaleo, M. A. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211023278 · Cited by 41
The role of mitochondrial-related nuclear genes in age-related common disease
Li, H., Slone, J. D., & Huang, T. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.04.012 · Cited by 42
Mitochondrial Control of Genomic Instability in Cancer
Bonora, M., Missiroli, S., Perrone, M., Fiorica, F., Pinton, P., & Giorgi, C. (2021) · Cancers · doi:10.3390/cancers13081914 · Cited by 42
Yebra, M., Bhargava, S., Kumar, A., Burgoyne, A. M., Tang, C.-M., Yoon, H., Banerjee, S., Aguilera, J., Cordes, T., Sheth, V. R., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2092 · Cited by 41
Li, Z., Yang, B., Yang, Z., Xie, X. N., Guo, Z., Zhao, J., Wang, R., Fu, H., Zhao, P., Zhao, X., et al. (2024) · Advanced Materials · doi:10.1002/adma.202307176 · Cited by 46
Johnson, T. I., Costa, A. S. H., Ferguson, A. N., & Frezza, C. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0912-3 · Cited by 40
The PLOD2/succinate axis regulates the epithelial–mesenchymal plasticity and cancer cell stemness
Tong, Y., Qi, Y., Xiong, G., Li, J., Scott, T. L., Chen, J., He, D., Li, L., Wang, C., Lane, A. N., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214942120 · Cited by 43
Metabolic Regulation of Epithelial to Mesenchymal Transition: Implications for Endocrine Cancer
Bhattacharya, D., & Scimè, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00773 · Cited by 39
Mitochondrial Redox Metabolism: The Epicenter of Metabolism during Cancer Progression
Choudhury, F. K. (2021) · Antioxidants · doi:10.3390/antiox10111838 · Cited by 44
How DNA methylation affects the Warburg effect
Zhu, X., Xuan, Z., Chen, J., Li, Z., Zheng, S., & Song, P. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45420 · Cited by 42
Tong, W.-H., Maio, N., Zhang, D., Palmieri, E. M., Ollivierre, H., Ghosh, M. C., McVicar, D. W., & Rouault, T. A. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018015669 · Cited by 36
Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2
Lv, D., Dixit, D., Cruz, A. F., Kim, L. J. Y., Duan, L., Xu, X. Y., Wu, Q., Zhong, C., Lu, C., Gersey, Z. C., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.014 · Cited by 47
Jiang, Q., Zhang, Y., Zhou, Y., Hou, Y., Wang, J., Li, J., Li, M., Tong, H., & Lu, W. (2015) · PubMed Central · Cited by 38
DNA methylation: a cause and consequence of type 2 diabetes
Kim, M. (2019) · Genomics & Informatics · doi:10.5808/gi.2019.17.4.e38 · Cited by 39
Schaefer, I., Hornick, J. L., & Bovée, J. V. M. G. (2018) · Laboratory Investigation · doi:10.1038/s41374-017-0003-6 · Cited by 36
Montano, E. N., Bose, M., Huo, L., Tumurkhuu, G., Santos, G. D. L., Simental, B., Stotland, A. B., Wei, J., Merz, C. N. B., Suda, J., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42724 · Cited by 40
Metabolism–epigenome crosstalk in physiology and diseases
Hino, S., Nagaoka, K., & Nakao, M. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.57 · Cited by 39
Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia
Takao, S., Chien, W., Madan, V., Lin, D.-C., Ding, L.-W., Sun, Q.-Y., Mayakonda, A., Sudo, M., Xu, L., Chen, Y., et al. (2017) · Leukemia · doi:10.1038/leu.2017.281 · Cited by 38
The Warburg effect: The hacked mitochondrial-nuclear communication in cancer
Jiang, H., & Ye, J. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.03.006 · Cited by 40
Gu, Y., Chen, J., Zhang, H., Shen, Z., Liu, H., Lv, S., Yu, X., Zhang, D., Ding, X., & Zhang, X. (2020) · The FASEB Journal · doi:10.1096/fj.201902957rr · Cited by 37
The metabolic adaptation mechanism of metastatic organotropism
Wang, C., & Luo, D. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-021-00223-4 · Cited by 40
Oncometabolic Nuclear Reprogramming of Cancer Stemness
Menéndez, J. A., Corominas-Faja, B., Cuyàs, E., García, M. G., Fernández‐Arroyo, S., Fernández, A. F., Joven, J., Fraga, M. F., & Alarcón, T. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.12.012 · Cited by 34
Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis
Ntranos, A., Ntranos, V., Bonnefil, V., Liu, J., Kim‐Schulze, S., He, Y., Zhu, Y., Brandstadter, R., Watson, C. T., Sharp, A. J., et al. (2018) · Brain · doi:10.1093/brain/awy344 · Cited by 37
Macklin, P. S., Yamamoto, A., Browning, L., Hofer, M., Adam, J., & Pugh, C. W. (2020) · The Journal of Pathology · doi:10.1002/path.5402 · Cited by 33
Proteolytic rewiring of mitochondria by LONP1 directs cell identity switching of adipocytes
Fu, T., Sun, W., Xue, J., Zhou, Z., Wang, W., Guo, Q., Chen, X., Zhou, D., Xu, Z., Liu, L., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01155-3 · Cited by 38
Self-citationMoonlighting Metabolic Enzymes in Cancer: New Perspectives on the Redox Code
Jiang, J., Peng, L., Wang, K., & Huang, C. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8123 · Cited by 31
Pregnancy Reprograms Large-Conductance Ca 2+ -Activated K + Channel in Uterine Arteries
Hu, X., Dasgupta, C., Chen, M., Xiao, D., Huang, X., Han, L., Yang, S., Xu, Z., & Zhang, L. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09059 · Cited by 38
Metabolic regulation by p53: Implications for cancer therapy
Koo, K. Y., Moon, K., He, S., & Lee, M.-S. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100198 · Cited by 45
Konieczna, A., Szczepańska, A., Sawiuk, K., Węgrzyn, G., & Łyżeń, R. (2015) · BMC Cell Biology · doi:10.1186/s12860-015-0062-8 · Cited by 33
Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells
Lü, J., Liang, Y., Meng, H., Zhang, A., Zhao, J., & Zhang, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.728783 · Cited by 34
Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma
Vícha, A., Taïeb, D., & Pacák, K. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0398 · Cited by 35
Peroxisome biogenesis in mammalian cells: The impact of genes and environment
Farr, R. L., Lismont, C., Terlecky, S. R., & Fransen, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.08.011 · Cited by 37
Molecular pathogenesis of tumorigenesis caused by succinate dehydrogenase defect
Moosavi, B., Zhu, X., Yang, W., & Yang, G. (2019) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2019.151057 · Cited by 37
Human Prostate Cancer Is Characterized by an Increase in Urea Cycle Metabolites
Frankó, A., Shao, Y., Heni, M., Hennenlotter, J., Hoene, M., Hu, C., Liu, X., Zhao, X., Wang, Q., Birkenfeld, A. L., et al. (2020) · Cancers · doi:10.3390/cancers12071814 · Cited by 35
Metabolic substrates, histone modifications, and heart failure
Huang, Z., Song, S., Zhang, X., Zeng, L., Sun, A., & Ge, J. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194898 · Cited by 35
Hu, X., Dasgupta, C., Xiao, J., Yang, S., & Zhang, L. (2018) · The Journal of Physiology · doi:10.1113/jp276058 · Cited by 33
Shao, J., Shi, T., Yu, H. T., Ding, Y., Li, L., Wang, X., & Wang, X. (2021) · The EMBO Journal · doi:10.15252/embj.2020107480 · Cited by 30
Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma
Lindner, A. K., Tulchiner, G. A., Seeber, A., Siska, P. J., Thurnher, M., & Pichler, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.906014 · Cited by 38
Mizumoto, A., Ohashi, S., Kamada, M., Saito, T., Nakai, Y., Baba, K., Hirohashi, K., Mitani, Y., Kikuchi, O., Matsubara, J., et al. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01549-x · Cited by 34
Innate immune training and metabolic reprogramming in primary monocytes of broiler and laying hens
Verwoolde, M. B., van den Biggelaar, R. H. G. A., Reilingh, G. D. V., Arts, J. A. J., van Baal, J., Lammers, A., & Jansen, C. A. (2020) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2020.103811 · Cited by 37
PAK4 Phosphorylates Fumarase and Blocks TGFβ-Induced Cell Growth Arrest in Lung Cancer Cells
Chen, T., Wang, T., Liang, W., Zhao, Q., Yu, Q., Ma, C., Zhuo, L., Guo, D. S., Zheng, K., Zhou, C., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2575 · Cited by 34
Trained immunity-inducing vaccines: Harnessing innate memory for vaccine design and delivery
Baydemir, İ., Dulfer, E. A., Netea, M. G., & Domínguez‐Andrés, J. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.109930 · Cited by 37
Omics Integration for Mitochondria Systems Biology
Hu, X. Y., Go, Y., & Jones, D. P. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.8006 · Cited by 35
Mito-Nuclear Communication in Hepatocellular Carcinoma Metabolic Rewiring
Mello, T., Simeone, I., & Galli, A. (2019) · Cells · doi:10.3390/cells8050417 · Cited by 34
Structure and function of dioxygenases in histone demethylation and DNA/RNA demethylation
Cheng, D., Zhang, H., Xu, C., Arrowsmith, C. H., & Min, J. (2014) · IUCrJ · doi:10.1107/s2052252514020922 · Cited by 33
Sano, A., Kakazu, E., Hamada, S., Inoue, J., Ninomiya, M., Iwata, T., Tsuruoka, M., Sato, K., & Masamune, A. (2021) · Hepatology · doi:10.1002/hep.31808 · Cited by 33
García‐Giménez, J. L., Cánovas‐Cervera, I., Nácher-Sendra, E., Dolz-Andrés, E., Sánchez-Bernabéu, Á., Agúndez, A. B., Hernández‐Gil, J., Mena, S., & Pallardó, F. V. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.04.004 · Cited by 36
TCA cycle-derived oncometabolites in cancer and the immune microenvironment
Sarkar, S., Chang, C.-I., Jean, J., & Wu, M. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01186-y · Cited by 39
Tanaka, Y., Konishi, A., Obinata, H., & Tsuneoka, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-55075-0 · Cited by 31
Regulation of tumor metabolism by post translational modifications on metabolic enzymes
Dessai, A. S., Kalhotra, P., Novickis, A. T., & Dasgupta, S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00521-x · Cited by 38
Altered Mitochondrial Signalling and Metabolism in Cancer
Chattopadhyay, E., & Roy, B. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00043 · Cited by 36
Advances and challenges in understanding histone demethylase biology
Nowak, R. P., Tumber, A., Johansson, C., Che, K. H., Brennan, P. E., Owen, D. R., & Oppermann, U. C. T. (2016) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2016.06.021 · Cited by 32
Li, A. M., & Ye, J. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-120857 · Cited by 31
Impact of Metabolic Pathways and Epigenetics on Neural Stem Cells
Fawal, M.-A., & Davy, A. (2018) · Epigenetics Insights · doi:10.1177/2516865718820946 · Cited by 31
Oxygen Concentration Controls Epigenetic Effects in Models of Familial Paraganglioma
Her, Y. F., Nelson-Holte, M. H., & Maher, L. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127471 · Cited by 34
Regulation of the 2-oxoglutarate-dependent dioxygenases and implications for cancer
Vissers, M. C. M., Kuiper, C., & Dachs, G. U. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140118 · Cited by 32
Metadata
- Authors
- Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., Zhao, S., Ye, D., Xiong, Y., & Guan, K.-L.
- Affiliations
- Fudan University (CN)
- Shanghai Medical College of Fudan University (CN)
- Chinese Academy of Sciences (CN)
- University of North Carolina at Chapel Hill (US)
- ORCID
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-06-07
- Volume
- 26
- Issue
- 12
- Pages
- 1326-1338
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC3387660
- OpenAlex
- W2104852749
- Semantic Scholar
- 0692bd51f83e69f21dab4f3e869a55299d72df6b
- Cited by
- 1,188
- References
- 50
- Citations by year
- 2026: 141 · 2025: 96 · 2024: 85 · 2023: 100 · 2022: 99 · 2021: 96 · 2020: 105 · 2019: 91 · 2018: 70 · 2017: 84 · 2016: 74 · 2015: 54 · 2014: 50 · 2013: 33 · 2012: 9
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- James S. McDonnell Foundation
- Samuel Waxman Cancer Research Foundation
- National Natural Science Foundation of China (2012CB910101, 2012CB910300, 30600112, 31071192, 81120108016, 30871255)
- National Institutes of Health
- Shanghai Leading Academic Discipline Project
- National Cancer Institute (F31CA260794)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- fumarate hydratase, succinate dehydrogenase, fumarate, succinic acid, alpha-ketoglutarate-dependent dioxygenase, histone demethylase, DNA demethylase, prolyl hydroxylase, collagen prolyl 4-hydroxylase, competitive inhibition, tumor suppressor mutations, epigenetic modifications, DNA methylation, histone methylation, TCA cycle, carcinogenesis
- MeSH terms
- Animals, Cells, Cultured, Fumarate Hydratase, Fumarates, Gene Expression Regulation, Humans, Ketoglutaric Acids, Models, Biological, Mutation, Succinate Dehydrogenase, Genome, Human, DNA Methylation, Succinic Acid, Tumor Suppressor Proteins, Endostatins, Dioxygenases, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Biocatalysis, Gene Knockdown Techniques, Histone Demethylases, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
